ESVAL KEVIN JAMES received a stock award from PANACEA LIFE SCIENCES HOLDINGS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 11/22/2019ACC: 0001415889-19-001388
Director
Since Jan 2019
+100K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
100K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+100K
Price / share
—
Trade value
—
% of position
40000.0%
11/20/2019
250.00→100.25K
Total
Net shares
+100K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/20/2019 | A · Award | +100K | — | — | 40000.0% | 250.00 | 100.25K |
| Total | +100K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned425K
Total
425K indirect425K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 425K | Indirect |
| Total | 425K | 425K indirect |
Derivative Holdings (Post-Transaction)2
Options to purchase common stock
DirectUnderlying security
Common Stock
Underlying shares
250K
Shares owned
250K
Exercise price
0.20
Expiration
—
Exercise window
—
Series B-2 Preferred Stock
IndirectUnderlying security
Common Stock
Underlying shares
168K
Shares owned
168K
Exercise price
Expiration
—
Exercise window
—
Total
Underlying
418K
Owned
418K
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Options to purchase common stock Direct | Common Stock | 0.20 | — | — | 250K | 250K |
| Series B-2 Preferred Stock Indirect | Common Stock | — | — | 168K | 168K | |
| Total | 418K | 418K | ||||